Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2008-A01187-48 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| BioFortis | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We put forward that probiotics have an effect on infectious episodes evolution in subjects aged 60 years or over. The main objective of this research is to observe the effect of consumption of the probiotic on the average number of days with infectious episodes.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 2 | Experimental | Subject with active product, not vaccinated against influenza. |
|
| 3 | Placebo Comparator | Subject with placebo, vaccinated against influenza. |
|
| 4 | Placebo Comparator | Subject with placebo, not vaccinated against influenza. |
|
| 1 | Experimental | Subject with active product, vaccinated against influenza |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lactobacillus helveticus R0052, Bifidobacterium bifidum R0071, Bifidobacterium infantis R0033 | Dietary Supplement | 1 pill per day for 12 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of infectious episodes | During the study |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jean Marc Cazaubiel, Dr | BioFortis | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Biofortis | Nantes | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Starch of potato | Dietary Supplement | 1 pill per day for 12 weeks |
|